title: Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct.
abstract: Studies in both monkeys and humans have suggested that transient infection with HIV-1 can occur without provoking a measurable humoral immune response. The objective of this study was to look for genetic and immunologic correlates of transient HIV-1 infection in antibody-negative men from whom HIV-1 had been isolated. The distributions of MHC class I, class II, and TAP (transporter protein associated with antigen processing) region genes were compared between 23 persistently seronegative men from whom HIV-1 was isolated at least once (isol+/Ab-) and 137 men who seroconverted. A subset of 13 of the 23 isol+/Ab- men were compared to 27 seronegative men for distribution of CD25+CD4+ and CD25+CD8+ cells in the absence of exogenous immunologic stimulation. The prevalences of the TAP1.4, and a combination of TAP1.4, and TAP2.3 variants were significantly higher in the isol+/Ab- men. The proportion of CD8+ cells that expressed CD25+ antigen was also significantly higher in the isol+/Ab- men than in the seronegative men. We conclude that isol+/Ab- men may be genetically and immunologically distinct from HIV-1 susceptible men. We hypothesize that activated CD8+ cells may have cleared HIV-1 infection in these men through genetically mediated influences of the TAP genes on the presentation of peptides by HLA class I molecules.
authors.affiliation: Los Angeles Center of the Multicenter AIDS Cohort Study, Department of Epidemiology, UCLA School of Public Health, USA.
authors.forename: R
authors.initials: R
authors.lastname: Detels
authors.forename: D
authors.initials: D
authors.lastname: Mann
authors.forename: M
authors.initials: M
authors.lastname: Carrington
authors.forename: K
authors.initials: K
authors.lastname: Hennessey
authors.forename: Z
authors.initials: Z
authors.lastname: Wu
authors.forename: K F
authors.initials: KF
authors.lastname: Hirji
authors.forename: D
authors.initials: D
authors.lastname: Wiley
authors.forename: B R
authors.initials: BR
authors.lastname: Visscher
authors.forename: J V
authors.initials: JV
authors.lastname: Giorgi
mesh_terms: D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters / Q000235:genetics / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D015483:HIV Antibodies / Q000276:immunology; D015658:HIV Infections / Q000235:genetics* / Q000276:immunology*; D018023:HIV Seronegativity / Q000235:genetics* / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D008285:Major Histocompatibility Complex / Q000235:genetics / Q000276:immunology; D008297:Male; D015375:Receptors, Interleukin-2 / Q000276:immunology
chemical_list: D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters; D015483:HIV Antibodies; D006680:HLA Antigens; D015375:Receptors, Interleukin-2; C073119:TAP1 protein, human; C071692:TAP2 protein, human